Mycophenolate Sodium bulk supplier for pharma manufacturers

Mycophenolate Sodium 180mg , 360 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 180mg , 360 mg

Reference Brands: Myfortic®(EU&US)

Mycophenolate Sodium Tablets are immunosuppressive medications used in nephrology to prevent organ rejection in kidney transplant patients. Marketed under the brand name Myfortic® in the US and EU, they offer a delayed-release formulation to reduce gastrointestinal side effects while ensuring effective immune suppression.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Mycophenolate Sodium Tablets are widely used in nephrology to prevent organ rejection in kidney transplant patients. This immunosuppressive agent, known for its delayed-release formulation, reduces gastrointestinal side effects while maintaining therapeutic efficacy. It is commonly marketed under the brand name Myfortic® in both the US and EU. Mycophenolate Sodium works by inhibiting the proliferation of T and B lymphocytes, crucial for immune response control post-transplantation. Ideal for inclusion in Pharma B2B nephrology product portfolios, these tablets offer high-quality, GMP-compliant manufacturing for global partners. Source Mycophenolate Sodium Tablets today to meet demand in renal care and transplant immunosuppression therapies. Mycophenolate Sodium Tablets are widely used in nephrology to prevent organ rejection in kidney transplant patients. This immunosuppressive agent, known for its delayed-release formulation, reduces gastrointestinal side effects while maintaining therapeutic efficacy. It is commonly marketed under the brand name Myfortic® in both the US and EU. Mycophenolate Sodium works by inhibiting the proliferation of T and B lymphocytes, crucial for immune response control post-transplantation. Ideal for inclusion in Pharma B2B nephrology product portfolios, these tablets offer high-quality, GMP-compliant manufacturing for global partners. Source Mycophenolate Sodium Tablets today to meet demand in renal care and transplant immunosuppression therapies.

Mycophenolate Sodium — third party manufacturing & bulk supply

Mycophenolate Sodium 180mg , 360 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Mycophenolate Sodium is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Mycophenolate Sodium listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Mycophenolate Sodium →

Back to Listing

Frequently Asked Questions

Mycophenolate Sodium is listed as Tablet in 180mg , 360 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Mycophenolate Sodium is referenced against Myfortic®(EU&US). Reference brands are shown for identification only and remain the property of their respective trademark owners.